Longeveron Inc-A

Penny Stocks Biotech Stocks Healthcare Stocks

$0.76

+0.00 (+0.65%)

As of May 16, 2:30 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +3,567.5% upside

Low Target $21.92

Average Target $27.69

High Target $40.08

Current Price $0.76

Current
$0.76

Target
$27.69

$21.92 $27.69 avg $40.08

Scenario Analysis

Bear Case

$21.92

2,803.3%

Low target

Base Case

$27.69

+3,567.5%

Avg target

Bull Case

$40.08

+5,208.6%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$1.80

-58.1% from high

52-Week Low

$0.48

+58.9% from low

Target vs 52W High

$27.69

+1,438.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%